Madison Avenue Partners

Madison Avenue Partners as of March 31, 2025

Portfolio Holdings for Madison Avenue Partners

Madison Avenue Partners holds 22 positions in its portfolio as reported in the March 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Graham Hldgs Com Cl B (GHC) 20.0 $236M 245k 960.86
Solventum Corp Com Shs (SOLV) 18.2 $214M 2.8M 76.04
Markel Corporation (MKL) 14.5 $171M 91k 1869.61
Wiley John & Sons Cl A (WLY) 8.4 $98M 2.2M 44.56
Theravance Biopharma (TBPH) 7.2 $85M 9.5M 8.93
Indivior Ord 6.3 $74M 7.8M 9.53
Magnera Corp Com Shs (MAGN) 5.2 $61M 3.3M 18.16
PG&E Corporation (PCG) 4.3 $51M 3.0M 17.18
Innovex International (INVX) 3.7 $43M 2.4M 17.96
Stagwell Com Cl A (STGW) 3.7 $43M 7.1M 6.05
Sage Therapeutics (SAGE) 3.0 $36M 4.5M 7.95
Nelnet Cl A (NNI) 2.2 $26M 234k 110.93
Columbus McKinnon (CMCO) 0.9 $11M 619k 16.93
Acelyrin 0.9 $10M 4.1M 2.47
Cannae Holdings (CNNE) 0.7 $7.7M 419k 18.33
Franklin Street Properties (FSP) 0.4 $4.9M 2.7M 1.78
2seventy Bio Common Stock 0.2 $2.9M 580k 4.94
Pliant Therapeutics (PLRX) 0.2 $2.3M 1.7M 1.35
Ovid Therapeutics (OVID) 0.1 $769k 2.5M 0.31
Sharkninja Com Shs (SN) 0.0 $513k 6.2k 83.41
Cargo Therapeutics (CRGX) 0.0 $411k 101k 4.07
Acadia Healthcare (ACHC) 0.0 $288k 9.5k 30.32